Literature DB >> 22670773

Alteration of CD1 expression in multiple sclerosis.

S Bine1, A Haziot, I Malikova, J Pelletier, D Charron, J Boucraut, N Mooney, C Gelin.   

Abstract

Studies of multiple sclerosis (MS) have concentrated mainly on antigen presentation of peptides derived from the myelin sheath, while the implication of lipid antigen has been less explored in this pathology. As the extracellular environment regulates expression of the lipid antigen-presenting molecule CD1, we have examined whether sera from patients alters CD1 surface expression in monocyte-derived dendritic cells. We have shown that: (i) CD1 group 1 proteins were highly expressed in the presence of MS sera; (ii) sera from MS patients differentially regulated CD1 group 1 versus CD1 group 2 molecular expression; and (iii) CD1 was expressed strongly in monocytes from MS patients under immunosuppressive treatment. Overall, these results reveal that CD1 expression is modified in MS and provide novel information on the regulation of lipid antigen presentation in myeloid cells.
© 2012 The Authors. Clinical and Experimental Immunology © 2012 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22670773      PMCID: PMC3390468          DOI: 10.1111/j.1365-2249.2012.04586.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

Review 1.  Multiple sclerosis.

Authors:  J H Noseworthy; C Lucchinetti; M Rodriguez; B G Weinshenker
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

2.  Bacterial infections promote T cell recognition of self-glycolipids.

Authors:  Gennaro De Libero; Anthony P Moran; Hans-Jürgen Gober; Emmanuel Rossy; Abdijapar Shamshiev; Olga Chelnokova; Zaima Mazorra; Silvia Vendetti; Alessandra Sacchi; Martina M Prendergast; Sebastiano Sansano; Alexander Tonevitsky; Regine Landmann; Lucia Mori
Journal:  Immunity       Date:  2005-06       Impact factor: 31.745

3.  A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.

Authors:  L S Madsen; E C Andersson; L Jansson; M krogsgaard; C B Andersen; J Engberg; J L Strominger; A Svejgaard; J P Hjorth; R Holmdahl; K W Wucherpfennig; L Fugger
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

4.  Self glycolipids as T-cell autoantigens.

Authors:  A Shamshiev; A Donda; I Carena; L Mori; L Kappos; G De Libero
Journal:  Eur J Immunol       Date:  1999-05       Impact factor: 5.532

Review 5.  Recognition of lipid antigens by T cells.

Authors:  Gennaro De Libero; Lucia Mori
Journal:  Nat Rev Immunol       Date:  2005-06       Impact factor: 53.106

6.  IgM ganglioside GM1 antibodies in patients with autoimmune disease or neuropathy, and controls.

Authors:  A S Bansal; B Abdul-Karim; R A Malik; P Goulding; R S Pumphrey; A J Boulton; P L Holt; P B Wilson
Journal:  J Clin Pathol       Date:  1994-04       Impact factor: 3.411

7.  Upregulation and atypical expression of the CD1 molecules on monocytes in sickle cell disease.

Authors:  Ivan Sloma; Marie-Thérèse Zilber; Dominique Charron; Robert Girot; Ryad Tamouza; Catherine Gelin
Journal:  Hum Immunol       Date:  2004-11       Impact factor: 2.850

8.  Sialic acid and fatty acid concentrations in lymphocytes, red blood cells and plasma from patients with multiple sclerosis.

Authors:  G D Cherayil
Journal:  J Neurol Sci       Date:  1984-01       Impact factor: 3.181

9.  Multiple sclerosis: expression of CD1a and production of IL-12p70 and IFN-gamma by blood mononuclear cells in patients on combination therapy with IFN-beta and glatiramer acetate compared to monotherapy with IFN-beta.

Authors:  Yassir Hussien; Alessandra Sanna; Mats Söderström; Hans Link; Yu-Min Huang
Journal:  Mult Scler       Date:  2004-02       Impact factor: 6.312

10.  In healthy primates, circulating autoreactive T cells mediate autoimmune disease.

Authors:  C P Genain; D Lee-Parritz; M H Nguyen; L Massacesi; N Joshi; R Ferrante; K Hoffman; M Moseley; N L Letvin; S L Hauser
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

View more
  1 in total

1.  CD1c-Expression by Monocytes - Implications for the Use of Commercial CD1c+ Dendritic Cell Isolation Kits.

Authors:  Martine Schrøder; Guro Reinholt Melum; Ole J B Landsverk; Anna Bujko; Sheraz Yaqub; Einar Gran; Henrik Aamodt; Espen S Bækkevold; Frode L Jahnsen; Lisa Richter
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.